Results 151 to 160 of about 3,650 (207)
[Depot medroxyprogesterone acetate as contraceptive agent].
Revista colombiana de obstetricia y ginecologia, 1975 openaire +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Long-acting injectable contraception with depot medroxyprogesterone acetate
American Journal of Obstetrics and Gynecology, 1994Depot medroxyprogesterone acetate (DMPA) is the only injectable contraceptive available in the United States. After more than 20 years of regulatory review, the Food and Drug Administration approved DMPA for contraceptive use in 1992 after the publication of reassuring data about its possible association with breast cancer.
Andrew M Kaunitz
exaly +3 more sources
Long-term depot-medroxyprogesterone acetate and bone mineral density
Contraception, 1999 The association between long-term use of depot-medroxyprogesterone acetate (DMPA) and bone mineral density (BMD) has been controversial, as seen in three case-control studies in New Zealand, Thailand, and the United Kingdom. In the present case-controlled study of BMD, a group of 67 Chinese women who had used DMPA from 5-15 years was compared with 218 ...
Li, B, Tang, G, Yip, P, Fan, S, Tang, OS
openaire +6 more sources
Depot-medroxyprogesterone acetate: an update
Archives of Gynecology and Obstetrics, 2008Depo-Provera is a contraceptive approved by the US Food and Drug Administration (FDA) since 1992 and used worldwide by more than 90 million women.Despite the fact that progestins are endogenous hormones that are secreted by the body, its excess might lead to detrimental health effects.
Sayed, Bakry +5 more
openaire +2 more sources
The Contraceptive Use of Depot Medroxyprogesterone Acetate
Clinical Obstetrics and Gynecology, 1995Depot medroxyprogesterone acetate (DMPA) was the first popular long-acting progestogen-only contraceptive and is used by more than nine million women worldwide. It is one of the most convenient and effective yet readily reversible methods of contraception.
M, Hickey, I, Fraser
openaire +2 more sources
Depot Medroxyprogesterone Acetate
2020Depot medroxyprogesterone acetate (DMPA) is an injectable progestin-only contraceptive administered every 13 weeks. DMPA is an extremely effective contraceptive agent when used consistently. With typical use, approximately 6 out of 100 women will become pregnant in the first year of use, reflecting that some users do not return for repeat injections ...
Deanna C. McCullough +2 more
openaire +1 more source
Injectable Contraception with Depot Medroxyprogesterone Acetate
Drugs, 1993Depot medroxyprogesterone acetate (DMPA) the only injectable contraception approved in the United States in 1992 is used by 8-9 million women in more than 90 countries. DMPA inhibits ovulation by the reduction of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) plasma levels.
Andrew M, Kaunitz, Allan, Rosenfield
openaire +2 more sources
Use of depot medroxyprogesterone acetate in Thai adolescents
Contraception, 2000Depot medroxyprogesterone acetate (DMPA) has been available for several decades in many parts of the world including Thailand, but few data have been reported concerning adolescents. The aim of the study was to determine the use of DMPA for contraceptive use among Thai adolescents. A cross-sectional study has been designed.
P, Chotnopparatpattara +1 more
openaire +2 more sources
Effect of depot medroxyprogesterone acetate on postpartum depression
Contraception, 2010Depot medroxyprogesterone acetate (DMPA) is commonly prescribed to women immediately postpartum due to its efficacy, convenience and lack of estrogen. It is unclear whether administering a progestin injection can affect the course of postpartum depression (PPD), which some suspect to be influenced by hormonal changes.
Rita, Tsai, Jonathan, Schaffir
openaire +2 more sources